ArticleFrontiers in oncology2022

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma.

Tiantian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.